Jun 22, 2026 04:10PM
Jun 22, 2026 04:10PM
Jun 18, 2026 08:00AM
Jun 18, 2026 08:00AM
Jun 8, 2026 07:01AM
Jun 8, 2026 07:00AM
Jun 2, 2026 08:00AM RedHill explores opaganib for ebola outbreak response
Jun 2, 2026 08:00AM
Apr 30, 2026 07:03AM
Apr 30, 2026 07:00AM
Apr 27, 2026 08:00AM
Apr 22, 2026 08:00AM
Mar 4, 2026 05:46PM
Feb 25, 2026 07:00AM Joint U.S. Commercialization of RedHill's Talicia® Commences
Jan 5, 2026 07:02AM
Jan 5, 2026 07:00AM
Dec 15, 2025 07:03AM
Dec 15, 2025 07:00AM
Dec 1, 2025 07:02AM
Dec 1, 2025 07:00AM
Nov 4, 2025 12:02PM RedHill Biopharma secures final $10.5 million court judgment
Nov 4, 2025 09:30AM
Nov 4, 2025 09:30AM
Nov 4, 2025 09:30AM
Oct 22, 2025 04:51PM
Oct 22, 2025 04:50PM
Oct 20, 2025 09:05AM
Oct 20, 2025 09:05AM CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
Oct 20, 2025 09:01AM
Oct 20, 2025 09:00AM
Oct 6, 2025 08:01AM
Oct 6, 2025 08:00AM
Sep 29, 2025 07:02AM
Sep 29, 2025 07:00AM
Sep 5, 2025 07:00AM RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
Aug 20, 2025 09:03AM
Aug 20, 2025 09:00AM
Aug 18, 2025 09:03AM
Aug 18, 2025 09:00AM
Jul 21, 2025 09:01AM
Jul 21, 2025 09:00AM
Jul 1, 2025 12:01PM RedHill Biopharma (RDHL) Announces Recruitment Initiated into Expanded Phase 2 Opaganib/Darolutamide Combination Study in Advanced Prostate Cancer
Jul 1, 2025 12:00PM
May 13, 2025 07:00AM
May 2, 2025 07:00AM
Apr 28, 2025 07:05AM
Apr 28, 2025 07:03AM
Apr 17, 2025 04:08PM
Apr 17, 2025 04:01PM RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
Apr 16, 2025 07:02AM

324,250 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All